Multiple Intracellular Signaling Pathways

Multiple Intracellular Signaling Pathways refers to the integrated network of biochemical circuits, such as the MAPK/ERK, PI3K/Akt/mTOR, and JAK/STAT pathways, that transmit external stimuli from the cell surface to the nucleus to elicit biological responses (Source: NIH National Cancer Institute). This term does not describe a single molecular target but rather a collective of pathways that govern fundamental cellular processes including growth, survival, and differentiation. In many diseases, particularly cancer and chronic inflammation, these pathways are frequently dysregulated or hyperactivated, driving pathological progression (Source: Nature Reviews Molecular Cell Biology). Pharmacological strategies often employ multi-target inhibitors to disrupt several of these pathways at once, which can be more effective than single-target therapies in preventing the activation of bypass signaling routes that lead to drug resistance. However, targeting multiple pathways simultaneously poses significant challenges regarding systemic toxicity and the maintenance of normal cellular homeostasis (Source: StatPearls).

Other names

Intracellular signaling cascadesSignal transduction networksCell signaling pathwaysMultiple signaling cascades

Drugs interacting with multiple pathways typically function as multi-kinase inhibitors or pleiotropic modulators that block several distinct signaling nodes (e.g., VEGFR, PDGFR, and RAF) simultaneously to prevent compensatory signaling and overcome resistance.